By continuing to use our site, you consent to the processing of cookies, user data (location information, type and version of the OS, the type and version of the browser, the type of device and the resolution of its screen, the source of where the user came from, from which site or for what advertisement, language OS and Browser, which pages are opened and to which buttons the user presses, ip-address) for the purpose of site functioning, retargeting and statistical surveys and reviews. If you do not want your data to be processed, please leave the site.
La voix des personnes atteintes d'un cancer du sein
October 22, 2014: Canadian Breast Cancer Network commends Ontario Ministry of Health for leadership on metastatic breast cancer
For Immediate Release
October 2014
The Canadian Breast Cancer Network (CBCN) commends the Ontario Ministry of Health for their swift action to expand access to new metastatic breast cancer treatments in the province.
Effective October 17th, the Ontario Ministry of Health announced that Cancer Care Ontario will, for a time-limited basis, provide access to Kadcyla through the New Drug Funding Program for HER-2 positive, metastatic breast cancer patients who have initiated or completed at least two lines of HER-2 targeted therapy and who have not received Kadcyla in previous lines of therapy.
The decision to provide Ontarians living with metastatic breast cancer greater access to new treatment options is a bold step in the right direction and will have an enormous impact on people battling serious illnesses. “We are so pleased to have worked with the Ministry of Health to promote expanded access to metastatic breast cancer treatments in Ontario,” said Cathy Ammendolea, Board Chair, Canadian Breast Cancer Network. “With this decision, Ontario has demonstrated great commitment towards optimizing patient outcomes and ensuring that Ontarians living with metastatic breast cancer can quickly and affordably access the potentially life-saving treatments they need.”
Providing access to new and more effective treatments gives patients a fighting chance to live much longer and spend precious time with loved ones. The Canadian Breast Cancer Network urges all provinces and jurisdictions to follow the leadership of Ontario and ensure that essential treatments for metastatic breast cancer are added to all provincial drug formularies.
-30-
For more information, please contact CBCN at 613-230-3044 or NChari@cbcn.ca
About the Canadian Breast Cancer Network
The Canadian Breast Cancer Network is the leading survivor-directed, national network of organizations and individuals concerned about breast cancer. The Canadian Breast Cancer Network exists to voice the concerns of breast cancer patients and survivors and promote the best quality of care for all Canadians affected by breast cancer.
PARTAGER
Nos témoignages
Inscrivez-vous dès maintenant pour recevoir des mises à jour par courriel
À propos du RCCS
Le RCCS s’efforce de faire valoir les perspectives et les préoccupations des patientes du cancer du sein en faisant de la sensibilisation, en organisant des activités de défense des intérêts et en promouvant le partage de l’information.
Réseau canadien du cancer du sein
185, rue Somerset ouest, suite 318, Ottawa, ON K2P 0J2
Tél : 613-230-3044
Sans frais : 1-800-685-8820
Écrivez-nous
